Tag Archives: XBI

April 17

Gilead’s (GILD) $1000 Pill

By David Nelson, CFA Gilead (GILD) was ground zero for the Biotech sell-off. The sector is down about 25% from its highs made earlier in the year and now (GILD) may be where the sector makes its stand. Unlike Amazon (AMZN), Netflix (NFLX), Tesla (TSLA) and others that have been hit hard by the recent […]

March 25

The Magnificent Seven of Old Tech

By David Nelson, CFA In the last few days we’ve seen a massive rotation from the market’s biggest winners to what investors refer to as Old Tech. For those of you not in the markets long enough to remember the Magnificent Seven, there was a time when (AAPL), (INTC), (MSFT), (IBM), (ORCL), (CSCO), & (EMC) […]

March 23

BNN In-Depth Interview – S&P – China – Trouble in the Biotech Sector

David talks with BNN host Mark Bunting about a range of topics on investors minds. Biotechs, the Fed, Index Investing are all covered during this in-depth interview.